Lyu, P., Ge, L., Ma, R., Wei, R., McCrudden, C. M., Chen, T., . . . Kwok, H. F. (2018). Identification and pharmaceutical evaluation of novel frog skin-derived serine proteinase inhibitor peptide–PE-BBI (Pelophylax esculentus Bowman-Birk inhibitor) for the potential treatment of cancer. Nature Portfolio.
Style de citation Chicago (17e éd.)Lyu, Peng, Lilin Ge, Rui Ma, Ran Wei, Cian M. McCrudden, Tianbao Chen, Chris Shaw, et Hang Fai Kwok. Identification and Pharmaceutical Evaluation of Novel Frog Skin-derived Serine Proteinase Inhibitor Peptide–PE-BBI (Pelophylax Esculentus Bowman-Birk Inhibitor) for the Potential Treatment of Cancer. Nature Portfolio, 2018.
Style de citation MLA (8e éd.)Lyu, Peng, et al. Identification and Pharmaceutical Evaluation of Novel Frog Skin-derived Serine Proteinase Inhibitor Peptide–PE-BBI (Pelophylax Esculentus Bowman-Birk Inhibitor) for the Potential Treatment of Cancer. Nature Portfolio, 2018.